Cadence’s Anirudh Devgan to Present at BofA Conference
Get Alerts CDNS Hot Sheet
Join SI Premium – FREE
SAN JOSE, Calif.--(BUSINESS WIRE)-- Cadence (Nasdaq: CDNS):
WHO:
Dr. Anirudh Devgan, president and chief executive officer, Cadence (Nasdaq: CDNS).
WHAT:
Dr. Devgan will participate in a fireside chat at the Bank of America (BofA) Securities 2026 Global Technology Conference in San Francisco on Wednesday, June 3, 2026.
WHEN:
The talk will be webcast live at 2:00 p.m. PDT. The presentation will be archived on the Cadence website and available for replay for one year.
WHERE:
The webcast will be available online at investor.cadence.com.
About Cadence
Cadence is a market leader in AI and digital twins, pioneering the application of computational software to accelerate innovation in the engineering design of silicon to systems. Our design solutions, based on Cadence’s Intelligent System Design™ strategy, are essential for the world’s leading semiconductor and systems companies to build their next-generation products from chips to full electromechanical systems that serve a wide range of markets, including hyperscale computing, mobile communications, automotive, aerospace, industrial, life sciences and robotics. In 2025, Cadence was recognized by Fortune as one of the world’s top 100 best companies to work for. Cadence® solutions offer limitless opportunities.
© 2026 Cadence Design Systems, Inc. All rights reserved worldwide. Cadence, the Cadence logo and the other Cadence marks found at www.cadence.com/go/trademarks are trademarks or registered trademarks of Cadence Design Systems, Inc. All other trademarks are the property of their respective owners.
Category: Financial
View source version on businesswire.com: https://www.businesswire.com/news/home/20260526142501/en/
For more information, please contact:
Investor Relations
Cadence Design Systems, Inc.
408-944-7100
[email protected]
Source: Cadence Design Systems, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA
- Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus
- Luvme Hair Recognized as America’s #1 Human Hair Wig Brand
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share